From: Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer
Cell Line | Pathway | P-value | Change in Expression |
---|---|---|---|
A2780 | MAPK signalling | 0.001 | Up-Regulated |
Focal adhesion | 0.002 | ||
Renal Cell Carcinoma | 0.01 | ||
Starch and Sucrose Metabolism | 0.04 | ||
Complement and Coagulation Cascade | 0.04 | ||
A2780cis | MAPK signalling | 0.02 | |
Focal adhesion | <0.001 | ||
Axon guidance | 0.002 | ||
TGF beta signalling | 0.007 | ||
Toll like receptor signalling | 0.02 | ||
DNA replication | <0.001 | ||
A2780 | Cell cycle | <0.001 | Down-regulated |
Pyrimidine metabolism | <0.001 | ||
Base Excision Repair | <0.001 | ||
Homologous Recombination | <0.001 | ||
DNA replication | <0.001 | ||
A2780cis | Cell cycle | <0.001 | |
Pyrimidine metabolism | 0.001 | ||
Base excision repair | 0.004 | ||
Oxidative phosphorylation | <0.001 |